查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
血漿蛋白治療市場，按產品類型、按應用、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1419029

血漿蛋白治療市場，按產品類型、按應用、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Plasma Protein Therapeutic Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 291 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年血漿蛋白治療市場規模為 300.53 億美元，2024 年至 2032 年CAGR為 6.5%。

血漿蛋白治療市場-市場動態

自體免疫疾病、免疫缺陷性疾病、神經系統和出血性疾病的增加預計將推動市場的成長。

血漿蛋白治療劑，例如血漿源性免疫球蛋白，用於治療特定的自體免疫疾病。自體免疫疾病盛行率的上升導致對血漿療法的需求不斷增加，從而推動市場擴張。根據從斯堪的納維亞國家等流行病學資源豐富的國家收集的綜合研究和資料，估計自體免疫疾病總共影響約 3% 的美國人口，相當於約 1000 萬人。為了更好地理解這一估計，考慮到美國目前的人口為 3.29 億。此外，預計市場上免疫缺陷性疾病、神經系統疾病和出血性疾病的發生率將激增，從而導致需要治療干預的患者數量增加。神經系統疾病的流行尤其會推動對這些治療方案的需求。全國不同地區各種神經系統疾病的盛行率從每10萬人口967例到4070例不等，平均為2394例，顯示超過3000萬人患有神經系統疾病。此外，治療技術的不斷進步，例如重組蛋白和工程血漿蛋白的開發，為市場創新提供了機會。然而，值得注意的是，高昂的治療成本以及潛在的污染和傳播風險可能會阻礙市場的成長。

血漿蛋白治療市場 - 關鍵見解

  • 根據我們的研究分析師分享的分析，預計全球血漿蛋白治療市場在預測期內（2024-2032）每年將以 6.5% 左右的CAGR成長
  • 根據產品類型細分，預計免疫球蛋白將在 2023 年顯示最大的市場佔有率
  • 根據應用細分，原發性免疫缺陷症（PIDD）是 2023 年的主導類型
  • 按地區分類，亞太地區是 2023 年的主要收入來源

血漿蛋白治療市場-細分分析：

全球血漿蛋白治療市場根據產品類型、應用和地區進行細分。

根據產品類型，市場分為三類：白蛋白、免疫球蛋白、血漿衍生因子 VIII 和其他。市場在很大程度上受到免疫球蛋白領域主導地位的影響。免疫球蛋白產品在血漿蛋白治療市場中具有重要意義，因為它們對於治療免疫缺陷性疾病、自體免疫疾病和神經系統疾病等一系列疾病至關重要。

根據應用，市場分為兩類：血友病、原發性免疫缺陷症（PIDD）、特發性血小板減少性紫斑症（ITP）和其他。該市場主要由原發性免疫缺陷症（PIDD）細分市場主導。在免疫系統受損的 PIDD 病例中，患者經常會出現抗體缺乏的情況。免疫球蛋白替代療法源自人類血漿，在 PIDD 的治療中發揮著至關重要的作用。這種療法需要施用免疫球蛋白來增強患者的免疫反應。

血漿蛋白治療市場 - 地理洞察

從地理來看，該市場遍佈北美、拉丁美洲、歐洲、亞太、中東和非洲等多個地區。這些區域根據參與商業活動的國家進一步分類。預計該市場的成長將由亞太地區主導，這主要是由於其完善的醫療基礎設施以及市場參與者在血漿蛋白療法研發方面的集中努力。近年來，亞太地區醫療基礎建設顯著成長，醫療設施、醫院、研究中心等方面的投資不斷增多，促進了醫療生態系統的整體改善。值得注意的是，中國政府已經成功建立了健全的醫療保健體系，考慮到中國作為世界上最大的發展中國家的地位，這是相當具有挑戰性的。經過歷屆政府的持續努力，預計到2021年底，中國內地醫療衛生機構總數將達到1030935個，其中醫院36570個，基層診所977790個。就市場規模而言，由於對先進治療方案的需求不斷成長以及發展中經濟體的成長，歐洲在預測期內佔據第二大地位。

血漿蛋白治療市場-競爭格局：

與傳統製藥業不同，血漿產業利用人體血漿（一種活細胞）作為生產救命藥物的主要材料。這些藥物的生產依賴於有限的原料供應，與生物技術設施中生長的非生命分子和生物製劑相比，原料的獲取通常更加昂貴且複雜。為了保持市場競爭力，持續的研究和開發工作至關重要。公司將投資用於開發新的和改進的血漿衍生產品、改進製造流程以及探索新的治療應用。生物技術的進步，例如重組蛋白的創建，是許多公司關注的領域，因為他們努力滿足對更安全、更永續的治療方案日益成長的需求。具有全球影響力的公司在進入多元化市場方面具有優勢。他們建立製造設施、分銷網路和合作夥伴關係，以確保其產品在各個地區的供應。隨著血漿衍生療法的需求持續上升，公司可能會堅持投資研發、探索策略合作夥伴關係並適應不斷變化的市場動態，以保持競爭優勢。

最新進展：

到 2023 年 5 月，Biotest AG 獲得了在另外 5 個國家銷售 Cytotect（一種 CMV 超級免疫球蛋白）的行銷授權，其市場現已覆蓋 28 個國家：捷克共和國、斯洛伐克、立陶宛、愛爾蘭和羅馬尼亞。

目錄

第1章：血漿蛋白治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的血漿蛋白治療市場片段
    • 血漿蛋白治療市場片段（依應用）
    • 按國家/地區分類的血漿蛋白治療市場片段
    • 按地區分類的血漿蛋白治療市場片段
  • 競爭洞察

第 3 章：血漿蛋白治療主要市場趨勢

  • 血漿蛋白治療市場促進因素
    • 市場促進因素的影響分析
  • 血漿蛋白治療市場限制
    • 市場限制影響分析
  • 血漿蛋白治療市場機會
  • 血漿蛋白治療市場未來趨勢

第 4 章：血漿蛋白治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：血漿蛋白治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：血漿蛋白治療市場格局

  • 2022 年血漿蛋白治療市佔分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：血漿蛋白治療市場 - 依產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 白蛋白
    • 免疫球蛋白
    • 血漿衍生因子 VIII
    • 其他

第 8 章：血漿蛋白治療市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 血友病
    • 原發性免疫缺陷症 (PIDD)
    • 特發性血小板減少性紫斑症 (ITP)
    • 其他

第 9 章：血漿蛋白治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美血漿蛋白治療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲血漿蛋白治療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區血漿蛋白治療主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲血漿蛋白治療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲血漿蛋白治療主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章：主要供應商分析 - 血漿蛋白治療產業

  • 競爭儀表板
  • 公司簡介
    • CSL
    • Grifols, SA
    • Takeda
    • Octapharma AG
    • Biotest AG
    • Kedrion SpA

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2094

REPORT HIGHLIGHT

Plasma Protein Therapeutic Market size was valued at USD 30,053 Million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.

Plasma protein therapies are exceptional biologic medications that are administered through infusion or injection to address a diverse range of uncommon, life-threatening, chronic, and genetic ailments. These conditions encompass bleeding disorders, immune deficiencies, pulmonary disorders, neurological disorders, shock and trauma, liver cirrhosis, as well as infectious diseases like tetanus, hepatitis, and rabies. The utilization of plasma-derived medicines is crucial for patients suffering from rare diseases that can solely be managed through these therapies. Moreover, these medicines play a vital role in everyday medical practices, emergency and critical care scenarios, and preventive medicine. On a daily basis, approximately 300,000 European patients heavily rely on plasma protein therapies to effectively treat various critical medical conditions. These conditions may include rare genetic diseases, chronic ailments, or life-threatening medical emergencies resulting from accidents and trauma. For these patients, plasma-derived medicines serve as a lifeline by aiding the body in replacing missing or deficient proteins. The absence of consistent access to these treatments would result in the loss of many lives or a significant decline in the quality of life for these individuals.

Plasma Protein Therapeutic Market- Market Dynamics

Increase in autoimmune disorders, immune deficiency disorders, neurological and bleeding disorders are projected to drive the growth of market.

Plasma protein therapeutics, such as plasma-derived immunoglobulins, are utilized in the treatment of specific autoimmune disorders. The rising prevalence of autoimmune diseases contributes to the increasing demand for plasma-based therapies, thereby propelling market expansion. Based on comprehensive research and data collected from countries with robust epidemiological resources, such as the Scandinavian countries, it is estimated that autoimmune diseases collectively affect approximately 3% of the US population, equivalent to around 10 million individuals. To better comprehend this estimation considers the current US population of 329 million. Additionally, the market is expected to witness a surge in the incidence of immune deficiency disorders, neurological disorders, and bleeding disorders, resulting in a larger patient pool necessitating therapeutic interventions. The prevalence of neurological disorders specifically can drive the demand for these therapeutic options. The prevalence rates of various neurological disorders across different regions of the country range from 967 to 4,070 per 100,000 population, with an average of 2,394, indicating that over 30 million people are affected by neurological disorders. Moreover, ongoing advancements in therapeutic technologies, such as the development of recombinant proteins and engineered plasma proteins, present opportunities for innovation within the market. However, it is important to note that the high cost of treatment and the potential risks of contamination and transmission may impede the growth of the market.

Plasma Protein Therapeutic Market- Key Insights

  • As per the analysis shared by our research analyst, the global Plasma Protein Therapeutic market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)
  • Based on product type segmentation, Immunoglobulin was predicted to show maximum market share in the year 2023
  • Based on application segmentation, Primary Immunodeficiency Disorder (PIDD) was the leading type in 2023
  • On the basis of region, Asia pacific was the leading revenue generator in 2023

Plasma Protein Therapeutic Market- Segmentation Analysis:

The Global Plasma Protein Therapeutic Market is segmented on the basis of Product Type, Application and Region.

The market is divided into three categories based on product type: Albumin, Immunoglobulin, Plasma-derived Factor VIII and Others. The market is largely influenced by the dominance of the Immunoglobulin segment. Immunoglobulin products hold significant importance in the Plasma Protein Therapeutic market as they are vital in treating a range of medical conditions such as immunodeficiency disorders, autoimmune diseases, and neurological disorders.

The market is divided into two categories based on application: Hemophilia, Primary Immunodeficiency Disorder (PIDD), Idiopathic Thrombocytopenic Purpura (ITP) and Others. The market is primarily dominated by the segment of Primary Immunodeficiency Disorder (PIDD). In cases of PIDD, where the immune system is compromised, patients frequently experience a deficiency in antibodies. Immunoglobulin Replacement Therapy, which is derived from human plasma, plays a crucial role in the management of PIDD. This therapy entails the administration of immunoglobulins to bolster the patient's immune response.

Plasma Protein Therapeutic Market- Geographical Insights

Geographically, this market is spread across various regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be dominated by the Asia Pacific region, primarily due to its well-established healthcare infrastructure and the focused efforts of market players in research and development for plasma protein therapeutics. In recent years, Asia Pacific has witnessed significant growth in its healthcare infrastructure, with investments being made in medical facilities, hospitals, and research centers, thereby contributing to the overall improvement of the healthcare ecosystem. Notably, the Chinese government has successfully established a robust healthcare system, which is quite challenging considering the country's status as the largest developing nation in the world. Through continuous efforts of successive governments, the Chinese mainland is projected to have a total of 1,030,935 healthcare institutions by the end of 2021, including 36,570 hospitals and 977,790 primary-level clinics. In terms of market size, Europe holds the second-largest position during the forecast period, driven by the increasing demand for advanced treatment options and the growth of developing economies.

Plasma Protein Therapeutic Market- Competitive Landscape:

In contrast to the conventional pharmaceutical industry, the plasma industry utilizes human blood plasma, a living cell, as its primary material for producing life-saving medications. The production of these medications relies on a limited supply of raw material, which is generally more expensive and complex to obtain compared to non-living molecules and biologics grown in biotechnology facilities. To remain competitive in the market, ongoing research and development efforts are crucial. Companies allocate investments towards the development of new and improved plasma-derived products, the enhancement of manufacturing processes, and the exploration of new therapeutic applications. Biotechnology advancements, such as the creation of recombinant proteins, are areas of focus for many companies as they strive to meet the increasing demand for safer and more sustainable treatment options. Companies with a global presence have an advantage in accessing diverse markets. They establish manufacturing facilities, distribution networks, and partnerships to ensure the availability of their products in various regions. As the demand for plasma-derived therapies continues to rise, companies are likely to persist in investing in research and development, exploring strategic partnerships, and adapting to evolving market dynamics to maintain their competitive edge.

Recent Advancements:

In May 2023, Biotest AG now has 28 nations on its market due to marketing authorizations it was granted to sell Cytotect, a CMV-hyper immunoglobulin, in five more countries: the Czech Republic, Slovakia, Lituania, Ireland, and Romania.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • CSL
  • Grifols, S.A.
  • Takeda
  • Octapharma AG
  • Biotest AG
  • Kedrion S.p.A

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Albumin
  • Immunoglobulin
  • Plasma-derived Factor VIII
  • Others

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hemophilia
  • Primary Immunodeficiency Disorder (PIDD)
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Others

GLOBAL PLASMA PROTEIN THERAPEUTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Plasma Protein Therapeutic Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Plasma Protein Therapeutic Market Snippet by Product Type
    • 2.1.2. Plasma Protein Therapeutic Market Snippet by Application
    • 2.1.3. Plasma Protein Therapeutic Market Snippet by Country
    • 2.1.4. Plasma Protein Therapeutic Market Snippet by Region
  • 2.2. Competitive Insights

3. Plasma Protein Therapeutic Key Market Trends

  • 3.1. Plasma Protein Therapeutic Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Plasma Protein Therapeutic Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Plasma Protein Therapeutic Market Opportunities
  • 3.4. Plasma Protein Therapeutic Market Future Trends

4. Plasma Protein Therapeutic Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Plasma Protein Therapeutic Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Plasma Protein Therapeutic Market Landscape

  • 6.1. Plasma Protein Therapeutic Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Plasma Protein Therapeutic Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Albumin
    • 7.1.3. Immunoglobulin
    • 7.1.4. Plasma-derived Factor VIII
    • 7.1.5. Others

8. Plasma Protein Therapeutic Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hemophilia
    • 8.1.3. Primary Immunodeficiency Disorder (PIDD)
    • 8.1.4. Idiopathic Thrombocytopenic Purpura (ITP)
    • 8.1.5. Others

9. Plasma Protein Therapeutic Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Plasma Protein Therapeutic Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Plasma Protein Therapeutic Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Plasma Protein Therapeutic Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Plasma Protein Therapeutic Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Plasma Protein Therapeutic Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Plasma Protein Therapeutic Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. CSL
    • 10.2.2. Grifols, S.A.
    • 10.2.3. Takeda
    • 10.2.4. Octapharma AG
    • 10.2.5. Biotest AG
    • 10.2.6. Kedrion S.p.A

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Plasma Protein Therapeutic Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Plasma Protein Therapeutic Market, by Product Type 2018-2030 (USD Million)
  • TABLE Plasma Protein Therapeutic Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Plasma Protein Therapeutic Market, by Application 2018-2030 (USD Million)
  • TABLE Plasma Protein Therapeutic Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Plasma Protein Therapeutic Market, by Region 2018-2030 (USD Million)
  • TABLE North America Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Plasma Protein Therapeutic Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Plasma Protein Therapeutic Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Plasma Protein Therapeutic Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Plasma Protein Therapeutic Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE Europe Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE Asia Pacific Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE Latin America Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE Middle East and Africa Plasma Protein Therapeutic Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Plasma Protein Therapeutic Market share analysis by country, 2022
  • FIGURE Germany Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Plasma Protein Therapeutic Market share analysis by country, 2022
  • FIGURE India Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Plasma Protein Therapeutic Market share analysis by country, 2022
  • FIGURE Brazil Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Plasma Protein Therapeutic Market share analysis by country, 2022
  • FIGURE Saudi Arabia Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Plasma Protein Therapeutic Market size, forecast and trend analysis, 2018 to 2030 (USD Million)